Commentary on Clinical Safety of Recombinant Human Parathyroid Hormone 1-34 in the Treatment of Osteoporosis in Men and Postmenopausal Women
-
- Armen H. Tashjian
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
-
- Bruce A. Chabner
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
収録刊行物
-
- Journal of Bone and Mineral Research
-
Journal of Bone and Mineral Research 17 (7), 1151-1161, 2002-07-01
Oxford University Press (OUP)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361699993945778688
-
- NII論文ID
- 30021655753
-
- ISSN
- 15234681
- 08840431
-
- Web Site
- https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1359%2Fjbmr.2002.17.7.1151
- https://onlinelibrary.wiley.com/doi/pdf/10.1359/jbmr.2002.17.7.1151
- https://onlinelibrary.wiley.com/doi/full-xml/10.1359/jbmr.2002.17.7.1151
- https://academic.oup.com/jbmr/article-pdf/17/7/1151/56468089/jbmr5650170703.pdf
-
- データソース種別
-
- Crossref
- CiNii Articles